Lilly(Eli) & Co

NYSE:LLY  
230.04
-1.00 (-0.43%)
4:00:00 PM EDT: $229.97 -0.07 (-0.03%)
Products

Eli Lilly And Co - FDA Approves Lyumjev For Use In Insulin Pumps

Published: 08/16/2021 11:08 GMT
Lilly(Eli) & Co (LLY) - FDA Approves Lyumjev® (insulin Lispro-aabc Injection) 100 Units/ml for Use in Insulin Pumps.
Eli Lilly - FDA Approves Lyumjev® (insulin Lispro-aabc Injection) 100 Units/ml for Use in Insulin Pumps.